FTI
78
-3
TRV
56
-2
ROK
67
5
ADM
24
2
EMN
50
-2
KEY
46
-2
EQR
60
6
VNO
60
8
SLB
56
-3
XOM
51
3
MA
67
-5
SJM
16
-3
LEG
31
3
UHS
54
-4
DOW
30
2
DUK
50
-2
DLTR
40
4
NSC
64
2
CF
53
2
LB
63
-4
FTI
78
-3
TRV
56
-2
ROK
67
5
ADM
24
2
EMN
50
-2
KEY
46
-2
EQR
60
6
VNO
60
8
SLB
56
-3
XOM
51
3
MA
67
-5
SJM
16
-3
LEG
31
3
UHS
54
-4
DOW
30
2
DUK
50
-2
DLTR
40
4
NSC
64
2
CF
53
2
LB
63
-4
Financhill
Back

Lyell Immunopharma Quote, Financials, Valuation and Earnings

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Sell
25

LYEL
Lyell Immunopharma

Last Price:
1.11
Seasonality Move:
-38.67%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Lyell Immunopharma Price Quote

$1.11
+0.01 (+0.91%)
(Updated: November 14, 2024 at 5:55 PM ET)

Lyell Immunopharma Key Stats

Sell
25
Lyell Immunopharma (LYEL) is a Sell
Day range:
$1.09 - $1.17
52-week range:
$0.85 - $3.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4,689.53
P/B ratio:
0.61%
Volume:
518.7K
Avg. volume:
1.5M
1-year change:
-29.03%
Market cap:
$323.9M
Revenue:
$130K
EPS:
$-0.79

How Much Does Lyell Immunopharma Make?

Is Lyell Immunopharma Growing As A Company?

  • What Is Lyell Immunopharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.36%
  • What Is Lyell Immunopharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Lyell Immunopharma Stock Price Performance

What Is Lyell Immunopharma 52-Week High & Low?

Lyell Immunopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lyell Immunopharma?

Is Lyell Immunopharma Cash Flow Positive?

  • What Is LYEL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$155.8M
  • What Is Lyell Immunopharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.6M
  • What Is Lyell Immunopharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$31.8M

Lyell Immunopharma Return On Invested Capital

  • Is Management Doing A Good Job?
    LYEL return on invested capital is -33.41%
  • What Is Lyell Immunopharma Return On Assets?
    ROA measures how assets are converting to revenues and is -29.04%
  • What Is LYEL Return On Equity?
    ROE is a measure of profitability and is -33.41%

Lyell Immunopharma Earnings Date & Stock Price

Lyell Immunopharma Competitors

Lyell Immunopharma Dividend Yield

Lyell Immunopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 36% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 2.00
Upside from Last Price: 81.82%

Major Shareholders

  • How many LYEL shares are owned by institutional investors?
    159.8M LYEL shares are owned by institutional investors
  • How many LYEL shares are owned by insiders?
    8.1M LYEL shares are owned by insiders